On June 20th, Fosun Pharma (2196.HK) rose 4.38% to HKD 13.82 in early trading. On the news front, Fosun Pharma announced that it sold a 6.01% stake in its Indian pharmaceutical subsidiary Gland Pharma for approximately USD 211 million (approximately HKD 1.646 billion). Gland Pharma is mainly engaged in the production and manufacturing of injectable pharmaceuticals and is listed on the main board of both the Mumbai Stock Exchange and the National Stock Exchange of India. After the transaction, Fosun Pharma will hold approximately 51.83% of Gland Pharma's shares and continue to maintain its controlling position.
港股异动丨复星医药一度涨超4%，减持印度药商股份套现逾16亿港元
Hong Kong stocks fluctuate | Fosun Pharma rose more than 4% at one point, with a shareholding of over 1.6 billion HK dollars for cashing in on Indian pharmaceutical shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.